WST: Raised guidance and strong HVP growth highlight robust momentum and strategic investment focus
Leadership transition is expected to accelerate growth, with Q2 results surpassing expectations and full-year guidance raised to 10%-11% growth. HVP components, biologics, and regulatory changes drive momentum, while investments focus on high-value solutions and expanding global reach.Based on West…